Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intrathecal sintilimab for leptomeningeal metastases of non-small cell lung cancer failed from targeted therapy and intrathecal chemotherapy (LMIS study)

Neuro-Oncology(2025)10.1093/neuonc/noaf025Source: DataRank Database

Intrathecal sintilimab for leptomeningeal metastases of non-small cell lung cancer failed from targeted therapy and intrathecal chemotherapy (LMIS study) is a research paper published in Neuro-Oncology (2025). On theSindex it has a DataRank of 0.330. It has been cited 8 times.

N/A

0.330DataRank · unranked

Scored on demand from live citation data

8 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 7.34)OA: greenTopics (52)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.330

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (16)

Yuanyuan Hu ORCID,Chong Teng ORCID,Yanju Lv,Xiaowei Song ORCID,Weixi Shen

Live enrichment

PubMed:39899029 PMC:PMC12309713 OpenAlex:https://openalex.org/W4407087251

Wu Jieping Medical Foundation

Grant: 320.6750.2022-16-3

Beijing Association for Cancer Control and Prevention

Grant: CAPTRALung2021008

FWCI

7.34

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12309713/

publisherhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noaf025/61741674/noaf025.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/27/6/1559/61741674/noaf025.pdf

journalhttps://doi.org/10.1093/neuonc/noaf025

Fields of Study

Brain Metastases and TreatmentLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesHumansCarcinoma, Non-Small-Cell LungLung NeoplasmsFemaleMaleMiddle AgedInjections, SpinalAntibodies, Monoclonal, HumanizedProspective StudiesAgedAdultMeningeal NeoplasmsSurvival RateFollow-Up StudiesPrognosisMolecular Targeted Therapy

MeSH Terms

AdultAgedCarcinoma, Non-Small-Cell LungFemaleFollow-Up StudiesHumansInjections, SpinalLung NeoplasmsMaleMeningeal NeoplasmsMiddle AgedPrognosisProspective StudiesSurvival RateMolecular Targeted TherapyAntibodies, Monoclonal, Humanized

Keywords

MedicineRashIntrathecalLung cancerAdverse effectClinical endpointChemotherapyIncidence (geometry)Internal medicineSurgeryOncologyClinical trialNon-small cell lung cancerImmune Checkpoint InhibitorsIntrathecal TreatmentSintilimabLeptomeningeal Metastatses

Sustainable Development Goals

SDG 0: Good health and well-being

Intrathecal sintilimab for leptomeningeal metastases of non-small cell lung cancer failed from targeted therapy and intrathecal chemotherapy (LMIS study)

FAIR Checklist

DataRank Breakdown

Authors (16)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)